Pruzanski W, Scott K, Smith G, Rajkovic I, Stefanski E, Vadas P
Inflammation Research Group, University of Toronto, Ontario, Canada.
Inflammation. 1992 Oct;16(5):451-7. doi: 10.1007/BF00918971.
Synovial fluid PLA2 concentration was measured by an ELISA technique using monoclonal antibodies raised against human recombinant "synovial-type" group II phospholipase A2. This ELISA was specific for synovial-type PLA2 and did not detect pancreatic (group I) PLA2. In all synovial fluids examined, including rheumatoid, osteoarthritic, psoriatic, and gouty fluids, synovial fluid PLA2 enzyme activity significantly correlated with PLA2 immunoreactivity (P < 0.001). Within the limits of the ELISA technique, there was no evidence for the presence of specific or nonspecific modulation of PLA2 activity by either putative PLA2 activating or inhibitory proteins.
采用酶联免疫吸附测定(ELISA)技术,使用针对人重组“滑膜型”II组磷脂酶A2产生的单克隆抗体,测量滑液中PLA2的浓度。该ELISA对滑膜型PLA2具有特异性,未检测到胰腺(I组)PLA2。在所有检测的滑液中,包括类风湿性、骨关节炎性、银屑病性和痛风性滑液,滑液PLA2酶活性与PLA2免疫反应性显著相关(P < 0.001)。在ELISA技术的检测范围内,没有证据表明存在假定的PLA2激活或抑制蛋白对PLA2活性的特异性或非特异性调节。